CSL (ASX:CSL) has outlined a restructuring plan that includes separating its Seqirus influenza vaccine business into a ...

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

SYDNEY (Reuters) -Australian biotech CSL has cut its profit outlook and delayed plans to spin off its vaccine division, blaming an unprecedented fall in U.S. flu immunisation rates, which knocked its ...

What's next for the beaten-down ASX biotech stock? The post CSL shares crash to a 9-year low. Is it time to sell off my ...

The Health Care (XHJ) industry inched 0.21% to close at 25375.2. CSL Ltd closed $59.78 short of its 52-week high ($184.62), which the company achieved on Tuesday, January 27. Trading volume of 3.9 ...

CSL Ltd (ASX: CSL) shares have sold off sharply. Here’s why I’d consider investing $20,000 with a long-term mindset.

After an antitrust review knocked 2021’s biggest biopharma buyout off course in May, CSL’s $11.7 billion deal for Swiss iron deficiency specialist Vifor Pharma appears to be back on track. Tuesday, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Earlier this year, BMW debuted the M4 CS, a car designed to sit between the Competition Package and the ultra-hardcore M4 GTS. Of course, bringing back the CS designation, which stands for Coupe Sport ...